| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adverse impact of infections on antibody responses to measles vaccination
|
Migasena, S.
|
|
1998
|
16 |
6 |
p. 647-652
6 p.
|
article
|
| 2 |
A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults
|
Marsano, Luis S.
|
|
1998
|
16 |
6 |
p. 624-629
6 p.
|
article
|
| 3 |
Combined antigent containing parts of three human cytomegalo virus proteins: fusion protein engineering for use as a recombinant vaccine
|
|
|
1998
|
16 |
6 |
p. 653-
1 p.
|
article
|
| 4 |
Combined intramuscular-intradermal protocol of universal neonate HB vaccination irrespective of mothers' status of HBsAg
|
Yao, Fu-Bao
|
|
1998
|
16 |
6 |
p. 586-589
4 p.
|
article
|
| 5 |
Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T)
|
Bell, Frank
|
|
1998
|
16 |
6 |
p. 637-642
6 p.
|
article
|
| 6 |
Erratum
|
|
|
1998
|
16 |
6 |
p. 655-
1 p.
|
article
|
| 7 |
Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene®, a hepatitis B vaccine containing pre-S1, pre-S2 and S gene products
|
Pride, Michael W.
|
|
1998
|
16 |
6 |
p. 543-550
8 p.
|
article
|
| 8 |
Homologous and heterologous antibody response of cattle and sheep after vaccination with foot and mouth disease and influenza viruses
|
Samina, Itzchak
|
|
1998
|
16 |
6 |
p. 551-557
7 p.
|
article
|
| 9 |
Immunogenicity of hepatitis B vaccines among infant recipients of acellular and whole cell pertussis DTP vaccines
|
Salmaso, S.
|
|
1998
|
16 |
6 |
p. 643-646
4 p.
|
article
|
| 10 |
Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1
|
Zamorano, P.I.
|
|
1998
|
16 |
6 |
p. 558-563
6 p.
|
article
|
| 11 |
Intracutaneous vaccination of rabbits with the E6 gene of cottontail rabbit papillomavirus provides partial protection against virus challenge
|
Sundaram, Pazhani
|
|
1998
|
16 |
6 |
p. 613-623
11 p.
|
article
|
| 12 |
Maternal measles antibody decay in rural Bangladeshi infants — implications for vaccination schedules
|
de Francisco, A.
|
|
1998
|
16 |
6 |
p. 564-568
5 p.
|
article
|
| 13 |
Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus
|
Jiang, Weiwen
|
|
1998
|
16 |
6 |
p. 601-607
7 p.
|
article
|
| 14 |
Phenotypic and genotypic alterations associated with the attenuation of a Theileria annulata vaccine cell line from Turkey
|
Somerville, Rob P.T.
|
|
1998
|
16 |
6 |
p. 569-575
7 p.
|
article
|
| 15 |
Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein
|
Nardin, E.H.
|
|
1998
|
16 |
6 |
p. 590-600
11 p.
|
article
|
| 16 |
Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum
|
Nieminen, T.
|
|
1998
|
16 |
6 |
p. 630-636
7 p.
|
article
|
| 17 |
Prostate-specific antigen multiple epitope peptide: plasmid or virus vector expression in e.g. dendrite cell for prostate cancer prevention or therapy
|
|
|
1998
|
16 |
6 |
p. 653-
1 p.
|
article
|
| 18 |
Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four and six months of age
|
Mills, Elaine
|
|
1998
|
16 |
6 |
p. 576-585
10 p.
|
article
|
| 19 |
Specific cellular and humoral immune response in Balb c mice immunised with an expression genomic library of Trypanosoma cruzi
|
Alberti, Esteban
|
|
1998
|
16 |
6 |
p. 608-612
5 p.
|
article
|
| 20 |
Stimulating humoral response with antigen and CD83 protein of DNA: expression from a bacterium or a virus vector, for use as a recombinant vaccine adjuvant, for e.g. autoimmune disease, transplant rejection, allergy, asthma, etc. prevention
|
|
|
1998
|
16 |
6 |
p. 653-
1 p.
|
article
|
| 21 |
Use of trypanosomatid histones, genes and derivatives: e.g. Leishmania major histone-H1 gene cloning and expression for use as a leishmaniasis recombinant vaccine or diagnostic agent
|
|
|
1998
|
16 |
6 |
p. 653-
1 p.
|
article
|
| 22 |
Vaccine for protecting against arthritogenic peptides containing danJp1 peptide: nucleic acid vaccine or recombinant vaccine against rheumatoid arthritis
|
|
|
1998
|
16 |
6 |
p. 653-
1 p.
|
article
|
Journal description